Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-25 @ 3:48 PM
Study NCT ID:
NCT05225259
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-02-28
First Post:
2022-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor
Sponsor:
Eli Lilly and Company
Organization: